← FDA Drug Approvals (Drugs@FDA)

OLOPATADINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS · Approved 2017-06-28

Drug application

FDA Application #
ANDA200810
Application type
Abbreviated New Drug Application (Generic)
Brand name
OLOPATADINE HYDROCHLORIDE
Generic name
OLOPATADINE HYDROCHLORIDE OPHTHALMIC
Active ingredients
OLOPATADINE HYDROCHLORIDE
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
Marketing status
Over-the-counter
Sponsor
GLENMARK PHARMS
Manufacturer
GLENMARK THERAPEUTICS INC., USA
First approval
2017-06-28

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown